Additional funding will avoid public services cliff-edge, says O'Dowd
Additional money for public services in Northern Ireland will avoid a potential funding 'cliff-edge', Stormont's Finance Minister John O'Dowd has said.
Mr O'Dowd said he had reached an agreement with the Treasury over an additional £600 million to support public services in the region.
He said it brought the total extra funding provided for the region to £1.3 billion.
Chief Secretary to the Treasury Darren Jones said the Northern Ireland Executive will 'receive the largest real-term settlement since the 1998 Good Friday Agreement' following the Government's spending review.
He added: 'The Executive will be receiving over 24% more per person than equivalent UK Government spending in the rest of the United Kingdom.
'That means the Executive will be receiving £19.3 billion per year on average between 2026-27 and 2028-29 with an average extra £1.2 billion through the Barnett formula per year, made up of £1 billion of day-to-day spending and £220 million of capital for that four-year period.'
Mr Jones said there would also be additional funding of £137 million over three years to tackle paramilitarism and organised crime, £11 million over three years to fund community development projects, £310 million over four years for city and growth deals and £185 million over three years for public service transformation and £2 million for integrated education.
Mr O'Dowd said agreement had been reached with the Treasury after months of negotiations.
He said: 'It will deliver an additional £600 million of funding provided for vital public services here.
'This will enable the Executive to take a long-term strategic approach to public service delivery.
'It helps avoid the potential cliff-edge in public funding that could have occurred when the restoration financial package comes to an end and the resulting damage this would have done to frontline public services.'
Mr O'Dowd said the Treasury had agreed to exclude £329 million of agriculture funding from the relative funding calculation for Northern Ireland.
He said: 'Without this agreement the Executive would have received £600 million less in funding over the spending review period.
'The agreement we have reached with Treasury will see us funded above 124% excluding agriculture between 2026-27 and 2028-29.
'The inclusion of agriculture and non-Barnett funding increases this to 128%.'
Mr O'Dowd added: 'Since taking up the role of Finance Minister I have consistently said I would do everything in my power to ensure our public services are fairly and properly funded.
'This agreement will see £600 million more for public services over the spending review period, providing additional investment in the services that we all rely on and delivers on my commitment to support workers, families and communities.'
People Before Profit MLA Gerry Carroll said the spending review had failed to deliver for working people in Northern Ireland.
He said: 'Once again, the British government has shown that its economic agenda is incapable of delivering for ordinary people.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
39 minutes ago
- Yahoo
5 Insightful Analyst Questions From Molina Healthcare's Q1 Earnings Call
Molina Healthcare's first quarter results were met with a negative market reaction, despite exceeding Wall Street revenue and non-GAAP EPS expectations. Management attributed the results to strong customer growth and disciplined medical cost management, but also acknowledged that the Marketplace segment faced one-time pressures from risk adjustment and membership reconciliations. CEO Joe Zubretsky described the company's consolidated medical cost ratio as 'reflect[ing] strong medical cost management and an improving rate environment,' but was quick to note that elevated costs in behavioral health, high-cost drugs, and seasonal illnesses were only partially offset by rate updates. Management's cautious approach and transparency about segment-level challenges indicated a more reserved outlook than in prior quarters. Is now the time to buy MOH? Find out in our full research report (it's free). Revenue: $11.15 billion vs analyst estimates of $10.86 billion (12.2% year-on-year growth, 2.6% beat) Adjusted EPS: $6.08 vs analyst estimates of $5.96 (2.1% beat) Adjusted EBITDA: $506 million vs analyst estimates of $520.8 million (4.5% margin, 2.8% miss) Adjusted EPS guidance for the full year is $24.50 at the midpoint, roughly in line with what analysts were expecting Operating Margin: 3.9%, in line with the same quarter last year Customers: 5.75 million, up from 5.54 million in the previous quarter Market Capitalization: $16.01 billion While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Stephen Baxter (Wells Fargo) asked for detail on Marketplace risk adjustment and membership reconciliation, to which CEO Joe Zubretsky and CFO Mark Keim explained these were non-recurring items that elevated costs and should not repeat, with Keim adding, 'the new integrity rules go a long way to stop churn and maybe some fraudulent activity.' Andrew Mok (Barclays) questioned the rationale behind higher Medicaid cost trend assumptions, and Zubretsky clarified that the guidance reflects 'appropriate conservatism' early in the year, with Keim confirming that most rate increases are already known and built into guidance. Josh Raskin (Nephron Research) inquired about the long-term role of Marketplace in Molina's strategy. Zubretsky emphasized Marketplace's synergy with Medicaid and Medicare, noting that it helps retain members as they move between public insurance options. John Stansel (JP Morgan) focused on G&A trends, with Zubretsky and Keim highlighting structural improvements and stating there is room for further scale-driven reductions in G&A ratio over time. Ryan Langston (TD Cowen) explored the effects of legislative uncertainty on M&A appetite. Zubretsky responded that uncertainty may actually increase acquisition opportunities, as smaller insurers seek scale or exit difficult markets. In upcoming quarters, the StockStory team will focus on (1) the timing and impact of further Medicaid rate adjustments as cost trends evolve, (2) evidence that Marketplace margins normalize as non-recurring items subside and new members are integrated, and (3) progress on integration of recent contract wins and acquisitions. We will also monitor legislative developments affecting Medicaid funding and any shifts in the competitive landscape that could impact Molina's growth trajectory. Molina Healthcare currently trades at $295.46, down from $331.67 just before the earnings. Is the company at an inflection point that warrants a buy or sell? The answer lies in our full research report (it's free). The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
Yahoo
an hour ago
- Yahoo
LevelJump Announces 2024 Financial Results
Toronto, Ontario--(Newsfile Corp. - June 20, 2025) - LevelJump Healthcare Corp. (TSXV: JUMP) ("LevelJump" or the "Company"), is pleased to announce its financial results for the year ended December 31, 2024. Financial and Operational Highlights Revenues were $17.7 million in 2024 compared to $12.6 million in revenues for 2023, a year over year revenue increase of 41%. Canadian Teleradiology Services, Inc., the Company's 100% owned subsidiary had EBITDA for 2024 of $3.35 million. 2024 Financial Results for fourth quarter and year Revenues of $4.8 million in Q4 2024 and $17.7 million for the year 2024 with a net profit of $1.95 million for Q4 2024 and a net profit of $1.2 million for the year 2024. EBITDA of $395,936 for Q4 2024 and $1,545,298 for the year 2024. Subsequent Events Subsequent to the year end, the Company entered an agreement to acquire two additional diagnostic imaging outpatient clinic locations in Calgary, Alberta. The transaction is expected to close towards the end of July 2025. See the Company's news release dated June 13, 2025. Management Comments "2024 was a transformative year for our Company, marked by significant growth, particularly within our clinic operations," said Mitch Geisler, CEO. "Our year-over-year revenue increased by more than 40%, and we achieved strong EBITDA performance. We are now interpreting imaging scans for approximately 200,000 patients annually across all operations. Our focus remains on driving organic growth and advancing our long-term vision for continued expansion." Non-IFRS Financial Measures This news release contains financial terms (such as adjusted EBITDA) that are not considered in IFRS. Such financial measures, together with measures prepared in accordance with IFRS, provide useful information to investors and shareholders, as management uses them to evaluate the operating performance of the Company. The Company's determination of these non-IFRS measures may differ from other reporting issuers and therefore are unlikely to be comparable to similar measures presented by other companies. Further, these non-IFRS measures should not be considered in isolation or as a substitute for measures of performance or cash flows prepared in accordance with IFRS. These financial measures are included because management uses this information to analyze operating performance and liquidity. For further details on the results, please refer to LevelJump's Management, Discussion and Analysis and Consolidated Financial Statements for the year ended December 31, 2024, which are available on the Company's website ( and under the Company's profile on SEDAR+ ( About LevelJump Healthcare LevelJump Healthcare Corp., (TSXV: JUMP) provides telehealth solutions to client hospitals and imaging centers through its Teleradiology division, as well as in person radiology services through its Diagnostic Centres. JUMP focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities we serve. ON BEHALF OF THE BOARD OF DIRECTORS OFLEVELJUMP HEALTHCARE CORP. Mitchell GeislerChief Executive Officerinfo@ CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable). Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release. The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
2 hours ago
- Bloomberg
Government Contractors Recruit Fewer Prospects
Thousands of private government consultants laid off during the Trump administration's cost-cutting crusade are increasingly flooding a shrinking labor market. Bloomberg's Rachel Phua has more on the story. (Source: Bloomberg)
